Activity of NaV1.2 promotes neurodegeneration in an animal model of multiple sclerosis
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Counteracting the progressive neurological disability caused by neuronal and axonal loss is the major unmet clinical need in multiple sclerosis therapy. However, the mechanisms underlying irreversible neuroaxonal degeneration in multiple sclerosis and its animal model experimental autoimmune encephalomyelitis (EAE) are not well understood. A long-standing hypothesis holds that the distribution of voltage-gated sodium channels along demyelinated axons contributes to neurodegeneration by increasing neuroaxonal sodium influx and energy demand during CNS inflammation. Here, we tested this hypothesis in vivo by inserting a human gain-of-function mutation in the mouse Na V 1.2-encoding gene Scn2a that is known to increase Na V 1.2-mediated persistent sodium currents. In mutant mice, CNS inflammation during EAE leads to elevated neuroaxonal degeneration and increased disability and lethality compared with wild-type littermate controls. Importantly, immune cell infiltrates were not different between mutant EAE mice and wild-type EAE mice. Thus, this study shows that increased neuronal Na V 1.2 activity exacerbates inflammation-induced neurodegeneration irrespective of immune cell alterations and identifies Na V 1.2 as a promising neuroprotective drug target in multiple sclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunopathology of multiple sclerosis
Dendrou, C. A., Fugger, L., & Friese, M. A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3871 · Cited by 2,215
Self-citationMechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis
Friese, M. A., Schattling, B., & Fugger, L. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.37 · Cited by 628 · cited 1×
“serves action potential conduction (8, 9), while persistent changes might be maladaptive and lead to axonal degeneration via a proposed cascade of intraaxonal sodium accumulation, subsequent axonal energy deprivation, axonal swelling, and calcium overload (3).”
BackgroundSelf-citationVeeramah, K. R., O'Brien, J. E., Meisler, M. H., Cheng, X., Dib-Hajj, S. D., Waxman, S. G., Talwar, D., Girirajan, S., Eichler, E. E., Restifo, L. L., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.01.006 · Cited by 438
Direct neuronal glucose uptake heralds activity-dependent increases in cerebral metabolism
Lundgaard, I., Li, B., Xie, L., Kang, H., Sanggaard, S., Haswell, J. D. R., Sun, W., Goldman, S., Blekot, S., Nielsen, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms7807 · Cited by 381
Kaplan, M. R., Cho, M.-H., Ullian, E. M., Isom, L. L., Levinson, S. R., & Barres, B. A. (2001) · Neuron · doi:10.1016/s0896-6273(01)00266-5 · Cited by 304
Molecular correlates of age-dependent seizures in an inherited neonatal-infantile epilepsy
Liao, Y., Deprez, L., Maljevic, S., Pitsch, J., Claes, L., Hristova, D., Jordanova, A., Ala-Mello, S., Bellan-Koch, A., Blazevic, D., et al. (2010) · Brain · doi:10.1093/brain/awq057 · Cited by 185 · cited 1×
“2 is known to be expressed by these cells (21).”
BackgroundSelf-citationSCN2A mutation associated with neonatal epilepsy, late-onset episodic ataxia, myoclonus, and pain
Liao, Y., Anttonen, A.-K., Liukkonen, E., Gaily, E., Maljevic, S., Schubert, S., Bellan-Koch, A., Petrou, S., Ahonen, V. E., Lerche, H., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f8812e · Cited by 170
Self-citationHedrich, U. B. S., Liautard, C., Kirschenbaum, D., Pofahl, M., Lavigne, J., Liu, Y., Theiss, S., Slotta, J., Escayg, A., Dihné, M., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.0721-14.2014 · Cited by 164 · cited 1×
“Brain slices were obtained as previously described (42).”
MethodSelf-citation
Cited by
Ion Channels in Genetic Epilepsy: From Genes and Mechanisms to Disease-Targeted Therapies
Oyrer, J., Maljevic, S., Scheffer, I. E., Berkovic, S. F., Petrou, S., & Reid, C. A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014456 · Cited by 315
Li, M., Jancovski, N., Jafar-Nejad, P., Burbano, L. E., Rollo, B., Richards, K., Drew, L., Sedo, A., Heighway, J., Pachernegg, S., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci152079 · Cited by 115
Bassoon proteinopathy drives neurodegeneration in multiple sclerosis
Schattling, B., Engler, J. B., Volkmann, C., Rothammer, N., Woo, M. S., Petersen, M., Winkler, I., Kaufmann, M., Rosenkranz, S. C., Fejtova, A., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0385-4 · Cited by 86
Self-citationDeciphering SCN2A : A comprehensive review of rodent models of Scn2a dysfunction
Scott, K. E. J., Hermosillo Arrieta, M. F., & Williams, A. J. (2025) · Epilepsia · doi:10.1111/epi.18615 · Cited by 9
Metadata
- Authors
- Schattling, B., Fazeli, W., Engeland, B., Liu, Y., Lerche, H., Isbrandt, D., & Friese, M. A.
- Venue
- JCI Insight
- Published
- 2016-11-17
- Volume
- 1
- Issue
- 19
- Pages
- e89810-e89810
- ISSN
- 2379-3708 (ISSN-L)
- OpenAlex
- W2554819882
- Cited by
- 44
- References
- 8
- FWCI
- 2.61
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Activity of NaV1.2 promotes neurodegeneration in an animal model of multiple sclerosis. https://app.cochat.ai/papers/10.1172/jci.insight.89810
- The paper
- Schattling, B., Fazeli, W., Engeland, B., Liu, Y., Lerche, H., Isbrandt, D., & Friese, M. A. (2016). Activity of NaV1.2 promotes neurodegeneration in an animal model of multiple sclerosis. JCI Insight. https://doi.org/10.1172/jci.insight.89810
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.